Nose-to-Brain Delivery of Cocaine in Mice: A Physiologically Based Pharmacokinetic Model Incorporating Olfactory Epithelial Transport, Mucociliary Clearance, and Blood-Brain Barrier Permeability

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Intranasal (IN) cocaine produces rapid central nervous system (CNS) effects despite generating substantially lower plasma concentrations than equivalent intravenous (IV) doses, suggesting a direct nose-to-brain pathway. The olfactory epithelium provides anatomical continuity for cocaine to pass between the nasal cavity and the brain. Quantifying the relative contribution of this pathway to total brain cocaine exposure requires a physiologically-based pharmacokinetic (PBPK) model that explicitly accounts for nasal mucosal architecture, epithelial transport barriers, and blood-brain barrier (BBB) permeability. Here we used tandem mass spectrometry to collect cocaine concentration-time data from the brain and plasma of awake mice administered IV or IN cocaine and leveraged that data to generate such a framework. Our results provide evidence that following IN cocaine, the olfactory pathway accounts for approximately half of the cocaine that reaches the brain. The mechanistic PBPK framework developed here — incorporating anatomically grounded nasal compartment separation, blood-flow-scaled mucosal absorption, tissue diffusion resistance, mucociliary clearance, plasma protein binding, and BBB permeability-surface area transport — substantially improves upon empirical one-compartment absorption models and produces parameter estimates with physiological interpretability. The proportionate efficiency of the olfactory route relative to systemic absorption may provide a pharmacokinetic basis for the rapid onset of IN cocaine’s CNS effects and has direct implications for understanding the psychoactive effects of cocaine.

Significance statement

Many drugs of abuse are inhaled, including cocaine, yet the mechanistic outcomes of inhaled cocaine are not understood compared to actions of cocaine following other ROAs. We established the pharmacokinetics of IN cocaine in awake mice, and developed a PBPK model to define the contributions of the olfactory pathway upon IN cocaine administration. Our findings demonstrate the contributions of a direct nose-to-brain pathway in mediating cocaine brain entry, thus, establishing the nasal ROA as a biological variable shaping pharmacokinetics and neurobiological outcomes of cocaine.

Article activity feed